The Process
The process is built on a framework of rigorous, multi-disciplinary due diligence and proactive, hands-on partnership. We ensure every investment aligns with our core thesis and receives the tailored support required for regulatory success and global scaling.
Thesis-Driven Sourcing and Due Diligence
We maintain strict discipline in our sourcing, evaluating only platforms that align with our core expertise in clinical diagnostics. Our vetting process is comprehensive and multi-disciplinary:
Technical & Clinical Validation:
Rigorous assessment of the scientific foundation, efficacy data, and clinical relevance.
Regulatory Pathways:
Deep mapping of the roadmap, potential risks, and opportunities for regulatory acceleration.
Financial Viability:
Building robust models for successful capital deployment, scaling, and eventual exit.
Intellectual Property (IP) Strategy:
Partnering with premier global IP and Securities law firms to secure and fortify the asset globally.
Active Operational Guidance
We are not passive investors. We adopt an active operational role, embedding our expertise directly into our startups to serve as an extension of the management team. We provide tailored support in four critical areas:
Regulatory & Clinical Trial Planning:
Directing submissions, managing trial logistics, and ensuring compliance.
Technical & Clinical Strategy:
Guiding validation, development roadmaps, and final product definition.
Financial Modeling & Fundraising:
Optimizing capital structure and preparing for subsequent funding rounds.
Intellectual Property (IP) Strategy:
Building protective moats around core technology and managing global rights.
Global Mindset
Our multilingual and international team comfortably operates across multiple jurisdictions (e.g., North America, Europe). This allows us to provide a truly expansive growth perspective for global market entry, ensuring our portfolio companies are positioned for worldwide commercial success from day one.